BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Willars C. Update in intensive care medicine: acute liver failure. Initial management, supportive treatment and who to transplant. Curr Opin Crit Care 2014;20:202-9. [PMID: 24584170 DOI: 10.1097/MCC.0000000000000073] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Teriaky A. The role of N-acetylcysteine in the treatment of non-acetaminophen acute liver failure. Saudi J Gastroenterol 2017;23:131-2. [PMID: 28611335 DOI: 10.4103/sjg.SJG_621_16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Vondran FW, Schumacher C, Johanning K, Hartleben B, Knitsch W, Wiesner O, Jaeckel E, Manns MP, Klempnauer J, Bektas H, Lehner F. Application of the Liver Maximum Function Capacity Test in Acute Liver Failure: A Helpful Tool for Decision-Making in Liver Transplantation? Case Rep Transplant 2016;2016:7074636. [PMID: 27274881 DOI: 10.1155/2016/7074636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Diao J, Li H, Huang W, Ma W, Dai H, Liu Y, Wang M, Hua HY, Ou J, Sun X, Sun X, Yang Y. SHYCD induces APE1/Ref-1 subcellular localization to regulate the p53-apoptosis signaling pathway in the prevention and treatment of acute on chronic liver failure. Oncotarget 2017;8:84782-97. [PMID: 29156683 DOI: 10.18632/oncotarget.19891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Ko SF, Chen YL, Sung PH, Chiang JY, Chu YC, Huang CC, Huang CR, Yip HK. Hepatic 31 P-magnetic resonance spectroscopy identified the impact of melatonin-pretreated mitochondria in acute liver ischaemia-reperfusion injury. J Cell Mol Med 2020;24:10088-99. [PMID: 32691975 DOI: 10.1111/jcmm.15617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]